While working at large medical corporations provides you a good label to add to your portfolio, Medical Device startup talent acquisition expert Mike Adamo admits that he has been focusing on placing people in smaller medical device companies.
Working in start-ups means visibility. Your efforts will not go unnoticed, given how small the team is. It also results in potential for faster career growth as it forces you to develop marketable skills. Larger companies tend to place people in their specialisations to increase efficiency, thus limiting your opportunity to dabble in other aspects of the company. In comparison, working in a start-up, with lesser manpower, will mean that you will be forced to get a go at everything. Furthermore, working in a smaller team with less bureaucracy means that things tend to move faster, i.e, shorter meeting times and decisions are made faster.
While there are more factors that Adamo brought up, the last point that will seem the most attractive is that there is equity. He claims that, “When you go to work at a start-up device company, chances are that every employee is an owner” and that means that if the company grows, it creates the opportunity for more equity and a significant payout when you build the company
With a funding of $100M, ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company that focuses on illnesses that are mainly found in Asian countries and also those that affect fewer than 200,000 people nationwide in the United States and Europe.
A Singapore-based telehealth company, Doctor Anywhere’s online platform is an easily accessible archive of medical information, such as health and wellness solutions, at the comfort of your own homes. Currently, it has a funding of $89.9M.
Doctor Anywhere is deemed one of the hottest health startups in Singapore, especially in light of the restrictions imposed during the pandemic. Not only does the platform provide solutions to your medical enquiries, there is a video conferencing function which allows users to consult with doctors. Users can also book medical appointments through the platform. (Tech Collective, 2021)
Holmusk has capitalised big data to combat chronic diseases with a cost-effective solution. It features a system that is built on users’ data to recommend lifestyle changes for that user to curb or improve their condition.
With an AI-driven surgical system, EndoMaster changes the face of endoscopic surgery by allowing surgeons to conduct incisionless surgery. This medical robotics startup currently has a funding of $14.5M but its novel system has resulted in creased precision and intuitiveness and reduced surgery time.
Lastly, with a funding of $15.3M, Biolidics specialises on developing medical devices in the cancer field.